Aceragen, Inc. ACGN

Market cap
$17.1M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Older periods Jun '22 Sep '22 Dec '22 Mar '23
ROE

+8 more TTM periods

(49.57%) (43.59%) (113.18%) (169.66%)
ROA
(41.25%) (16.41%) (34.36%) (75.58%)
ROIC
0.00% (27.83%) (64.66%) (135.35%)
Return on Tangible Assets
(69.90%) (108.03%) 657.47% 335.83%
Average Days of Receivables
— 411.75 239.65 91.58
Free Cash Flow per Share
(5.41) (4.90) (7.52) (4.00)
Free Cash Flow
(16.84) (15.34) (24.49) (29.78)
Piotroski F-Score
0.00 2.00 3.00 4.00
Other line items
Cash ROIC
(36.40%) (14.58%) (48.05%) (120.73%)
Accounts Receivable Turnover
— 1.74 0.00 0.00
Accounts Payable Turnover
0.11 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 — —
Average Days of Payables
2,843.16 154,235.31 0.00 0.00
Days of Inventory on Hand
0.00 0.00 — —
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
0.00% 463.18% 190.17% 175.36%
Selling, General and Administrative Expense of Revenue
0.00% 536.59% 190.56% 167.82%
Share Based Compensation of Revenue
0.00% 118.61% 34.14% 32.73%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.15 1.31 1.05 0.73
Depreciation/Fixed assets
1.36 1.45 2.14 2,771.25
Capex/Depreciation
0.00 0.00 0.00 0.00
Revenue per Share
0.00 0.56 1.97 1.18
Operating CF per Share
(5.41) (4.90) (7.52) (4.00)
Capex per Share
0.00 0.00 0.00 0.00
Capex to Sales
— 0.00 0.00 0.00
Net Profit Margin
0.00% (673.23%) (364.49%) (467.53%)

Fold the line items

Columns are period end dates